CEBPA and Alzheimer disease: Decreased expression of SPI1 and CEBPA (also identified through motif enrichment analysis in macrophages) is observed after a reduction in AD-like pathology and behaviour in APPswe/PSEN1dE9 mice following pharmacological inhibition of the receptor CSF1R [34].